194 related articles for article (PubMed ID: 26322696)
1. Early virological and immunological events in Epstein-Barr virus infection.
Hislop AD
Curr Opin Virol; 2015 Dec; 15():75-9. PubMed ID: 26322696
[TBL] [Abstract][Full Text] [Related]
2. Infectious mononucleosis and Epstein-Barr virus.
Vetsika EK; Callan M
Expert Rev Mol Med; 2004 Nov; 6(23):1-16. PubMed ID: 15541197
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
4. The ins and outs of EBV infection.
Faulkner GC; Krajewski AS; Crawford DH
Trends Microbiol; 2000 Apr; 8(4):185-9. PubMed ID: 10754578
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
[TBL] [Abstract][Full Text] [Related]
8. [Chronic active Epstein-Barr virus infection].
Kimura H
Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
[TBL] [Abstract][Full Text] [Related]
9. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Epstein-Barr virus infection.
Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study.
Chiereghin A; Piccirilli G; Belotti T; Prete A; Bertuzzi C; Gibertoni D; Gabrielli L; Turello G; Borgatti EC; Barbato F; Sessa M; Arpinati M; Bonifazi F; Lazzarotto T
Med Microbiol Immunol; 2019 Dec; 208(6):825-834. PubMed ID: 31289930
[TBL] [Abstract][Full Text] [Related]
12. The role of Epstein-Barr virus in epithelial malignancies.
Tsao SW; Tsang CM; To KF; Lo KW
J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730
[TBL] [Abstract][Full Text] [Related]
13. Vaccine Development for Epstein-Barr Virus.
Cohen JI
Adv Exp Med Biol; 2018; 1045():477-493. PubMed ID: 29896681
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Wingate PJ; McAulay KA; Anthony IC; Crawford DH
J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
[TBL] [Abstract][Full Text] [Related]
15. [Regulation and evasion of host immune responses by Epstein-Barr virus].
Xiao N; Chen Q; Cai S
Wei Sheng Wu Xue Bao; 2016 Jan; 56(1):19-25. PubMed ID: 27305776
[TBL] [Abstract][Full Text] [Related]
16. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
Auerbach A; Aguilera NS
Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
[TBL] [Abstract][Full Text] [Related]
18. The immunology of Epstein-Barr virus-induced disease.
Taylor GS; Long HM; Brooks JM; Rickinson AB; Hislop AD
Annu Rev Immunol; 2015; 33():787-821. PubMed ID: 25706097
[TBL] [Abstract][Full Text] [Related]
19. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
20. Epstein Barr virus - a tumor virus that needs cytotoxic lymphocytes to persist asymptomatically.
Münz C
Curr Opin Virol; 2016 Oct; 20():34-39. PubMed ID: 27591678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
